Regeneron Pharmaceuticals (REGN)

Operating Income Growth

31.59%

Quarterly · Period ending:

REGN logo

REGN Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported31.59%
REGN Quarterly Operating Income YoY % (66.67% → 31.59%)
High-resolution chart · PNG

REGN operating income growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Operating Income Growth — Quarterly
Period endingOperating Income Growth
31.5887%
8.653%
-11.1392%
-12.9462%
0.9256%
-21.2537%
-5.7581%
-2.6012%
5.2238%
-25.0698%
-20.1232%
-1.0378%
-22.2205%
-22.0581%
-50.1686%
-33.7538%
-60.9554%
15.6287%
126.1954%
75.4059%
409.933%
58.9344%
72.7098%
42.5999%
107.9848%
45.8542%
-5.9045%
17.7976%
-49.2758%
-15.3784%
33.2749%
11.9653%
13.061%
31.7481%
55.2756%
54.3338%
88.7034%
30.7414%
50.1644%
-7.548%
-15.4356%
16.1363%
-6.5833%
108.2212%
51.1943%
48.0215%
16.6424%
-20.4128%
44.2667%
25.163%
45.5845%
17.0178%
75.129%
589.3834%
420.8449%
446.1758%
249.6676%
154.1739%
-537.6518%
-82.1431%
-154.2531%
-42.9952%
126.3246%
-2,385.9799%
-45.8502%
-67.2249%
-13.8992%
93.5227%
17.0906%
-7.7116%
-199.974%
48.4548%
35.894%
52.7148%
65.5558%
-36.8404%
-26.2073%
-55.3294%
-22.5965%
17.8265%
24.6153%
23.5603%
-787.3176%
-262.7703%
-154.4254%
-219.1057%
-95.0947%
63.121%
53.0558%
183.8437%
30.5772%
20.12%
10.0768%
-12.6464%
121.2503%
-38.1343%
-65.6069%
-71.2528%
394.8686%
-50.41%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.